{"disease":{"id":"dlbcl-germinal-center-b-cell-type","name":"dlbcl germinal center b cell type"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05422066","title":"Selinexor Plus R-CHOP in High-risk GCB-subtype Diffuse Large B-Cell Lymphoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Li Zhiming","has_results":false},{"nct_id":"NCT04933617","title":"Copanlisib With Dose-Adjusted EPOCH-R in Relapsed and Refractory Burkitt Lymphoma and Other High-Grade B-cell Lymphomas","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":8,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}